Literature DB >> 12805457

Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.

Robert A Love1, Hans E Parge, Xiu Yu, Michael J Hickey, Wade Diehl, Jingjin Gao, Hilary Wriggers, Anne Ekker, Liann Wang, James A Thomson, Peter S Dragovich, Shella A Fuhrman.   

Abstract

The virus-encoded nonstructural protein 5B (NS5B) of hepatitis C virus (HCV) is an RNA-dependent RNA polymerase and is absolutely required for replication of the virus. NS5B exhibits significant differences from cellular polymerases and therefore has become an attractive target for anti-HCV therapy. Using a high-throughput screen, we discovered a novel NS5B inhibitor that binds to the enzyme noncompetitively with respect to nucleotide substrates. Here we report the crystal structure of NS5B complexed with this small molecule inhibitor. Unexpectedly, the inhibitor is bound within a narrow cleft on the protein's surface in the "thumb" domain, about 30 A from the enzyme's catalytic center. The interaction between this inhibitor and NS5B occurs without dramatic changes to the structure of the protein, and sequence analysis suggests that the binding site is conserved across known HCV genotypes. Possible mechanisms of inhibition include perturbation of protein dynamics, interference with RNA binding, and disruption of enzyme oligomerization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805457      PMCID: PMC164784          DOI: 10.1128/jvi.77.13.7575-7581.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  The HIV-1 reverse transcription (RT) process as target for RT inhibitors.

Authors:  H Jonckheere; J Anné; E De Clercq
Journal:  Med Res Rev       Date:  2000-03       Impact factor: 12.944

2.  Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  S Bressanelli; L Tomei; A Roussel; I Incitti; R L Vitale; M Mathieu; R De Francesco; F A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor.

Authors:  J V Prasad; F E Boyer; J M Domagala; E L Ellsworth; C Gajda; H W Hamilton; S E Hagen; L J Markoski; B A Steinbaugh; B D Tait; C Humblet; E A Lunney; A Pavlovsky; J R Rubin; D Ferguson; N Graham; T Holler; D Hupe; C Nouhan; P J Tummino; A Urumov; E Zeikus; G Zeikus; S J Gracheck; J W Erickson
Journal:  Bioorg Med Chem       Date:  1999-12       Impact factor: 3.641

4.  A mechanism for initiating RNA-dependent RNA polymerization.

Authors:  S J Butcher; J M Grimes; E V Makeyev; D H Bamford; D I Stuart
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

5.  Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  H Ago; T Adachi; A Yoshida; M Yamamoto; N Habuka; K Yatsunami; M Miyano
Journal:  Structure       Date:  1999-11-15       Impact factor: 5.006

6.  5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease.

Authors:  F E Boyer; J V Vara Prasad; J M Domagala; E L Ellsworth; C Gajda; S E Hagen; L J Markoski; B D Tait; E A Lunney; A Palovsky; D Ferguson; N Graham; T Holler; D Hupe; C Nouhan; P J Tummino; A Urumov; E Zeikus; G Zeikus; S J Gracheck; J M Sanders; S VanderRoest; J Brodfuehrer; K Iyer; M Sinz; S V Gulnik
Journal:  J Med Chem       Date:  2000-03-09       Impact factor: 7.446

Review 7.  Hepatitis C virus RNA-dependent RNA polymerase (NS5B polymerase).

Authors:  C H Hagedorn; E H van Beers; C De Staercke
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

8.  Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo.

Authors:  A A Kolykhalov; K Mihalik; S M Feinstone; C M Rice
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

9.  Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  J Schmidt-Mende; E Bieck; T Hugle; F Penin; C M Rice; H E Blum; D Moradpour
Journal:  J Biol Chem       Date:  2001-11-23       Impact factor: 5.157

10.  Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site.

Authors:  C A Lesburg; M B Cable; E Ferrari; Z Hong; A F Mannarino; P C Weber
Journal:  Nat Struct Biol       Date:  1999-10
View more
  39 in total

1.  Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.

Authors:  Anita Y M Howe; Huiming Cheng; Ian Thompson; Srinivas K Chunduru; Steve Herrmann; John O'Connell; Atul Agarwal; Rajiv Chopra; Alfred M Del Vecchio
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 2.  Structure-function relationships among RNA-dependent RNA polymerases.

Authors:  Kenneth K S Ng; Jamie J Arnold; Craig E Cameron
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

3.  Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.

Authors:  Hongmei Mo; Liangjun Lu; Tami Pilot-Matias; Ron Pithawalla; Rubina Mondal; Sherie Masse; Tatyana Dekhtyar; Teresa Ng; Gennadiy Koev; Vincent Stoll; Kent D Stewart; John Pratt; Pam Donner; Todd Rockway; Clarence Maring; Akhteruzzaman Molla
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.

Authors:  Weidong Hao; Koleen J Herlihy; Noelle Jie Zhang; Shella A Fuhrman; Chau Doan; Amy K Patick; Rohit Duggal
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication.

Authors:  Leen Delang; Inge Vliegen; Mathy Froeyen; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

6.  Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.

Authors:  Joanne E Tomassini; Krista Getty; Mark W Stahlhut; Sung Shim; Balkrishen Bhat; Anne B Eldrup; Thazha P Prakash; Steven S Carroll; Osvaldo Flores; Malcolm MacCoss; Daniel R McMasters; Giovanni Migliaccio; David B Olsen
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

7.  Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees.

Authors:  Steven S Carroll; Steven Ludmerer; Larry Handt; Kenneth Koeplinger; Nanyan Rena Zhang; Donald Graham; Mary-Ellen Davies; Malcolm MacCoss; Daria Hazuda; David B Olsen
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

8.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors.

Authors:  Frederik Pauwels; Wendy Mostmans; Ludo M M Quirynen; Liesbet van der Helm; Carlo W Boutton; Anne-Stéphanie Rueff; Erna Cleiren; Pierre Raboisson; Dominique Surleraux; Origène Nyanguile; Kenneth A Simmen
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stephanie T Shi; Koleen J Herlihy; Joanne P Graham; Shella A Fuhrman; Chau Doan; Hans Parge; Michael Hickey; Jingjin Gao; Xiu Yu; Fannie Chau; Javier Gonzalez; Hui Li; Cristina Lewis; Amy K Patick; Rohit Duggal
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.